ヘルスケアコンサルティングサービス市場 – 2030年までの世界予測

本レポートは、ヘルスケアコンサルティングサービス市場をサービスタイプ、エンドユーザー、地域別に分析しています。 市場の成長に影響を与える要因（促進要因、抑制要因、機会、課題）を分析しています。 ステークホルダーにとっての市場の機会と課題を評価し、市場リーダーの競争環境を詳細に説明しています。 マイクロ市場の成長傾向、見通し、そしてヘルスケアコンサルティングサービス市場全体への貢献について調査しています。 5つの地域における市場セグメントの収益予測も行っています。

The healthcare consulting services market is projected to reach USD 51.95 billion by 2030 from USD 32.17 billion in 2025, at a CAGR of 10.1% during the forecast period. The growing demand for adopting electronic health records, telehealth, and AI-driven diagnostics, along with the shift toward value-based care and operational cost pressures, is driving demand for expert advisory services. Additionally, expanding healthcare infrastructure in emerging markets and innovation in pharma and MedTech fuel market growth.

ヘルスケアコンサルティングサービス市場は、2025年の321.7億米ドルから2030年には519.5億米ドルに達し、予測期間中は年平均成長率（CAGR）10.1%で成長すると予測されています。電子カルテ、遠隔医療、AIを活用した診断の導入需要の高まり、価値に基づくケアへの移行、そして運用コストの圧力が、専門家によるアドバイザリーサービスの需要を押し上げています。さらに、新興市場におけるヘルスケアインフラの拡大と、製薬・医療技術におけるイノベーションも市場の成長を牽引しています。

By service type, the IT & digital transformation consulting services segment is expected to dominate the market during the forecast period.

By service type, the healthcare consulting services market is segmented into IT & digital transformation consulting services; strategy consulting services; operation consulting services; financial consulting services; HR & talent consulting services; marketing, sales, and commercialization consulting services; regulatory & compliance; R&D consulting services; public health consulting services; and other services. The highest growth rate of the IT & digital transformation consulting services segment is attributed to the increasing adoption of electronic health records (EHRs) and telemedicine platforms; the utilization of AI for diagnostics & operations; the importance of cloud computing; and the advancement of cybersecurity solutions.

By end user, the pharmaceutical & biotechnology companies segment accounted for the largest market share in 2024.

The healthcare consulting services market is segmented by end users into government bodies, healthcare providers, health insurance payers, pharmaceutical & biotechnological companies, medical device companies, and other end users. The pharmaceutical & biotechnological companies segment accounted for the largest market share in 2024. This dominance is driven by their growing need for cost optimization in API operations, formulation development, and supply chain management. These companies also face complex and frequently changing regulatory requirements, necessitating expert guidance on compliance, mergers and acquisitions, product launch strategies, and brand management.

By region, North America accounted for the largest market share in 2024.

The global healthcare consulting services market is segmented into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. In 2024, North America accounted for the largest market share. The large share of this segment is attributed to the highly developed healthcare infrastructure, substantial healthcare spending, widespread adoption of digital health technologies, and strong regulatory frameworks. The presence of leading healthcare consulting firms, advanced payer-provider models, and continuous investment in value-based care, AI, and patient experience further reinforces North America’s leadership in the sector.

The breakdown of primary participants is as mentioned below:

• By Company Type – Tier 1 (31%), Tier 2 (28%), and Tier 3 (41%)
• By Designation – C-level Executives (31%), Director-level (25%), and Managers (44%)
• By Region – North America (45%), Europe (28%), the Asia Pacific (20%), Latin America (4%), and the Middle East & Africa (3%)

Key Players

The prominent players in this market are Accenture Plc (Ireland), Cognizant Technology Solutions Corporation (US), Deloitte (UK), McKinsey & Company (UK), PwC (UK), Ernst & Young Global Limited (EY) (UK), Huron Consulting Group Inc. (US), and KPMG (UK), among others.

Research Coverage

• The report studies the healthcare consulting services market based on service type, end user, and region.
• The report analyzes factors (drivers, restraints, opportunities, and challenges) affecting the market growth.
• The report evaluates the market’s opportunities and challenges for stakeholders and details the competitive landscape for market leaders.
• The report studies micro-markets regarding their growth trends, prospects, and contributions to the total healthcare consulting services market.
• The report forecasts the revenue of market segments in five regions.

Reasons to Buy the Report

The report can help established and new entrants/smaller firms gauge the market’s pulse, which, in turn, would help them garner a greater share. Firms purchasing the report could use one or a combination of the five strategies mentioned below.

This report provides insights into the following pointers:

Analysis of key drivers (Growing rate of digitization in healthcare, Increasing adoption of big data analytics, IoT, and cloud deployment in the healthcare industry, changing healthcare landscape with respect to regulatory compliance and technological evolution, decreasing number of in-house experts in the end-use industries, rising level of government support for HCIT solutions, growing need for structural changes and new business models in the healthcare industry, increasing number of patients suffering from various chronic and infectious diseases, and increasing pressure to reduce the rising healthcare costs), restraints (rising number of concerns regarding data confidentiality, increasing number of hidden costs of consulting services), opportunities (growing demand for cloud consulting, increasing potential for healthcare consulting services in the emerging markets, increasing consolidation in the healthcare industry), and challenges (rising number of multi-sourcing approaches, high cost of consulting services) influencing the growth of the healthcare consulting services market.

• Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and product launches in the healthcare consulting services market.
• Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various healthcare consulting services solutions across regions.
• Market Diversification: Exhaustive information about products, untapped regions, recent developments, and investments in the Healthcare consulting services market.
• Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the healthcare consulting services market.

Table of Contents

1               INTRODUCTION              25

1.1           STUDY OBJECTIVES       25

1.2           MARKET DEFINITION   25

1.3           MARKET SCOPE                26

1.3.1        MARKET SEGMENTATION AND REGIONAL SCOPE                 26

1.3.2        INCLUSIONS AND EXCLUSIONS 27

1.3.3        YEARS CONSIDERED      28

1.4           CURRENCY CONSIDERED            28

1.5           STAKEHOLDERS               29

2               RESEARCH METHODOLOGY       30

2.1           RESEARCH DATA              30

2.1.1        SECONDARY DATA          31

2.1.1.1    Key data from secondary sources       31

2.1.2        PRIMARY DATA 32

2.1.2.1    Key data from primary sources           33

2.1.2.2    Breakdown of primary interviews      34

2.2           MARKET SIZE ESTIMATION         35

2.2.1        SUPPLY-SIDE ANALYSIS                 36

2.2.2        BOTTOM-UP APPROACH              38

2.2.3        COMPANY PRESENTATIONS AND PRIMARY INTERVIEWS      39

2.2.4        GROWTH FORECAST      39

2.3           MARKET BREAKDOWN AND DATA TRIANGULATION                 43

2.4           RESEARCH ASSUMPTIONS           44

2.4.1        PARAMETRIC ASSUMPTIONS     44

2.4.2        STUDY-RELATED ASSUMPTIONS              44

2.5           RESEARCH LIMITATIONS             45

2.5.1        METHODOLOGY-RELATED LIMITATIONS           45

2.5.2        SCOPE-RELATED LIMITATIONS                 45

2.6           RISK ANALYSIS  45

3               EXECUTIVE SUMMARY  46

4               PREMIUM INSIGHTS       49

4.1           HEALTHCARE CONSULTING SERVICES MARKET OVERVIEW          49

4.2           ASIA PACIFIC HEALTHCARE CONSULTING SERVICES MARKET, BY COUNTRY AND END USER 50

4.3           HEALTHCARE CONSULTING SERVICES MARKET: REGIONAL GROWTH OPPORTUNITIES 51

4.4           HEALTHCARE CONSULTING SERVICES MARKET: REGIONAL MIX 51

4.5           HEALTHCARE CONSULTING SERVICES MARKET: EMERGING VS. DEVELOPED MARKETS  52

5               MARKET OVERVIEW       53

5.1           INTRODUCTION              53

5.2           MARKET DYNAMICS       53

5.2.1        DRIVERS               54

5.2.1.1    Growing trend of digitization             54

5.2.1.2    Increasing adoption of big data analytics, IoT, and cloud deployment            55

5.2.1.3    Changing healthcare landscape          56

5.2.1.4    Rising government support for HCIT solutions              57

5.2.1.5    Emergence of new business models  57

5.2.1.6    Growing incidence of chronic and infectious diseases   58

5.2.1.7    Need for data security          59

5.2.1.8    Increasing pressure to reduce healthcare costs                60

5.2.2        RESTRAINTS      60

5.2.2.1    Data confidentiality concerns             60

5.2.2.2    Hidden costs of consulting services   61

5.2.3        OPPORTUNITIES              61

5.2.3.1    Rising trend of consolidation              61

5.2.3.2    Opportunities in emerging markets  62

5.2.3.3    Consistent rise in mergers and acquisitions     62

5.2.4        CHALLENGES    63

5.2.4.1    Rising number of multi-sourcing approaches  63

5.3           INDUSTRY TRENDS         63

5.3.1        DIGITAL TRANSFORMATION IN HEALTHCARE  63

5.3.2        SHIFT TOWARD VALUE-BASED CARE     63

5.3.3        FOCUS ON PATIENT-CENTRIC CARE       63

5.3.4        RISING IMPORTANCE OF SOCIAL DETERMINANTS OF HEALTH               64

5.3.5        EXPANDING USE OF DATA ANALYTICS 64

5.3.6        GROWTH OF PRECISION MEDICINE        64

5.4           TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS            65

5.5           INDICATIVE PRICING ANALYSIS                65

5.5.1        INDICATIVE PRICING ANALYSIS, BY TYPE OF SERVICE                 66

5.5.2        INDICATIVE PRICING ANALYSIS, BY REGION      66

5.6           VALUE CHAIN ANALYSIS               67

5.7           ECOSYSTEM ANALYSIS  68

5.8           INVESTMENT AND FUNDING SCENARIO               69

5.9           TECHNOLOGY ANALYSIS             70

5.9.1        KEY TECHNOLOGIES     71

5.9.1.1    Machine learning 71

5.9.1.2    Artificial intelligence            71

5.9.1.3    Cloud computing  71

5.9.1.4    Big data and advanced analytics         71

5.9.2        COMPLEMENTARY TECHNOLOGIES       72

5.9.2.1    Robotic Process Automation (RPA) 72

5.9.2.2    Natural Language Processing (NLP)                72

5.9.3        ADJACENT TECHNOLOGIES       72

5.9.3.1    Blockchain             72

5.9.3.2    Internet of Things (IoT)     72

5.10         KEY CONFERENCES AND EVENTS, 2025–2026        73

5.11         CASE STUDY ANALYSIS 74

5.11.1      ENHANCED PATIENT EXPERIENCE WITH PAPERLESS PROCESS              74

5.11.2      ADVANCED CLOUD SOLUTION TO IMPROVE HUMAN CAPITAL MANAGEMENT CAPABILITIES 74

5.11.3      DEVELOPMENT OF RISK MANAGEMENT PLANS FOR EFFECTIVE TREATMENT              75

5.12         REGULATORY LANDSCAPE         76

5.12.1      REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS             76

5.12.2      REGULATORY ANALYSIS               79

5.12.2.1  North America      79

5.12.2.2  Europe   80

5.12.2.3  Asia Pacific            80

5.12.2.4  Middle East & Africa            81

5.12.2.5  Latin America       81

5.13         PORTER’S FIVE FORCES ANALYSIS           81

5.13.1      BARGAINING POWER OF SUPPLIERS       82

5.13.2      BARGAINING POWER OF BUYERS             83

5.13.3      THREAT OF NEW ENTRANTS      83

5.13.4      THREAT OF SUBSTITUTES          83

5.13.5      INTENSITY OF COMPETITIVE RIVALRY 83

5.14         KEY STAKEHOLDERS AND BUYING CRITERIA     84

5.14.1      KEY STAKEHOLDERS IN BUYING PROCESS           84

5.14.2      BUYING CRITERIA           85

5.15         BUSINESS MODELS         85

5.16         IMPACT OF 2025 US TARIFF         86

5.16.1      INTRODUCTION              86

5.16.2      KEY TARIFF RATES          87

5.16.3      PRICE IMPACT ANALYSIS             87

5.16.4      IMPACT ON COUNTRY/REGION                88

5.16.4.1  US           88

5.16.4.2  Europe   88

5.16.4.3  Asia Pacific            89

5.16.5      IMPACT ON END-USE INDUSTRIES          89

6               HEALTHCARE CONSULTING SERVICES MARKET, BY TYPE OF SERVICE            91

6.1           INTRODUCTION              92

6.2           IT/DIGITAL TRANSFORMATION CONSULTING  93

6.2.1        RISING DEMAND FOR MODERNIZATION AND VALUE-BASED CARE DELIVERY TO AID GROWTH             93

6.3           STRATEGY CONSULTING             94

6.3.1        RAPID TECHNOLOGICAL ADVANCEMENTS TO FACILITATE GROWTH   94

6.4           OPERATIONS CONSULTING        95

6.4.1        TRANSITION FROM FEE-FOR-SERVICE TO COORDINATED CARE MODEL TO SUSTAIN GROWTH    95

6.5           FINANCIAL CONSULTING            97

6.5.1        RISING NEED FOR OPTIMIZED REVENUE CYCLE MANAGEMENT TO STIMULATE GROWTH            97

6.6           HR & TALENT CONSULTING       98

6.6.1        ONGOING SHORTAGE OF HEALTHCARE PROFESSIONALS TO PROMOTE GROWTH            98

6.7           MARKETING, SALES, AND COMMERCIALIZATION CONSULTING    99

6.7.1        INNOVATIONS IN DRUG DEVELOPMENT AND MEDICAL TECHNOLOGY TO DRIVE MARKET          99

6.8           REGULATORY & COMPLIANCE  100

6.8.1        RAPID ADOPTION OF DIGITAL HEALTH TECHNOLOGIES TO AUGMENT GROWTH            100

6.9           R&D CONSULTING          101

6.9.1        GROWING DEMAND FOR NEW DRUGS TO BOOST MARKET               101

6.10         PUBLIC HEALTH CONSULTING 102

6.10.1      INCREASING INVESTMENTS IN PUBLIC HEALTH INFRASTRUCTURE TO FOSTER GROWTH             102

6.11         OTHER CONSULTING SERVICES                103

7               HEALTHCARE CONSULTING SERVICES MARKET, BY END USER            105

7.1           INTRODUCTION              106

7.2           GOVERNMENT BODIES 106

7.2.1        GROWING INVESTMENTS IN MODERNIZING DIGITAL AND TECHNOLOGY INFRASTRUCTURE TO FUEL MARKET                 106

7.3           HEALTHCARE PROVIDERS           108

7.3.1        HOSPITALS         109

7.3.1.1    Growing need for telehealth and remote care to propel market                 109

7.3.2        AMBULATORY CARE CENTERS  111

7.3.2.1    Rising demand for convenient and patient-centered services to bolster growth       111

7.3.3        LONG-TERM CARE FACILITIES  112

7.3.3.1    Booming geriatric population to contribute to growth   112

7.3.4        DIAGNOSTIC & IMAGING CENTERS         113

7.3.4.1    Rising global demand for early disease detection, precision diagnostics, and outpatient imaging services to favor growth       113

7.3.5        OTHER HEALTHCARE PROVIDERS           114

7.4           HEALTH INSURANCE PAYERS    115

7.4.1        PRIVATE PAYERS              116

7.4.1.1    Need for regulatory compliance to encourage growth    116

7.4.2        PUBLIC PAYERS                117

7.4.2.1    Growing digital transformation initiatives to boost market                 117

7.5           PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES                 118

7.5.1        EVOLVING LIFE SCIENCES LANDSCAPE TO SPUR GROWTH             118

7.6           MEDICAL DEVICE COMPANIES 119

7.6.1        GROWING FOCUS OF MEDICAL DEVICE COMPANIES ON CUTTING-EDGE TECHNOLOGY TO DRIVE MARKET        119

7.7           OTHER END USERS         120

8               HEALTHCARE CONSULTING SERVICES MARKET, BY REGION                122

8.1           INTRODUCTION              123

8.2           NORTH AMERICA             123

8.2.1        MACROECONOMIC OUTLOOK FOR NORTH AMERICA                 125

8.2.2        US           127

8.2.2.1    Advanced infrastructure and high healthcare spending to augment growth    127

8.2.3        CANADA               130

8.2.3.1    Shift toward technology-driven integrated healthcare model to spur growth            130

8.3           EUROPE               133

8.3.1        MACROECONOMIC OUTLOOK FOR EUROPE      133

8.3.2        GERMANY           136

8.3.2.1    Increasing emphasis on electronic documentation and compliance to spur growth  136

8.3.3        UK          139

8.3.3.1    Need for sectoral restructuring to accelerate growth      139

8.3.4        FRANCE                142

8.3.4.1    Need to ensure interoperability and compatibility among healthcare IT systems to aid growth  142

8.3.5        ITALY    145

8.3.5.1    Expansion of digital health sector to support growth      145

8.3.6        SPAIN    148

8.3.6.1    Growing digitization of healthcare systems to boost market                 148

8.3.7        REST OF EUROPE             150

8.4           ASIA PACIFIC     152

8.4.1        MACROECONOMIC OUTLOOK FOR ASIA PACIFIC                 153

8.4.2        JAPAN   157

8.4.2.1    Increasing adoption of information technology in medical care and home nursing to promote growth               157

8.4.3        CHINA  160

8.4.3.1    Favorable government initiatives to bolster growth        160

8.4.4        INDIA    163

8.4.4.1    Growing adoption of connected healthcare ecosystem to boost market    163

8.4.5        REST OF ASIA PACIFIC   166

8.5           LATIN AMERICA                168

8.5.1        MACROECONOMIC OUTLOOK FOR LATIN AMERICA                 169

8.5.2        BRAZIL 171

8.5.2.1    Ongoing efforts to modernize healthcare infrastructure to promote growth    171

8.5.3        MEXICO                174

8.5.3.1    Rising healthcare costs to contribute to growth               174

8.5.4        REST OF LATIN AMERICA             176

8.6           MIDDLE EAST & AFRICA                178

8.6.1        MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 179

8.6.2        GCC COUNTRIES              181

8.6.2.1    Increasing investments in healthcare infrastructure to contribute to growth                181

8.6.3        REST OF MIDDLE EAST & AFRICA             184

9               COMPETITIVE LANDSCAPE         187

9.1           OVERVIEW          187

9.2           KEY PLAYER STRATEGIES/RIGHT TO WIN            187

9.2.1        OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN HEALTHCARE CONSULTING SERVICES MARKET          187

9.3           REVENUE ANALYSIS, 2020–2024  190

9.4           MARKET SHARE ANALYSIS, 2024                 191

9.5           COMPANY VALUATION AND FINANCIAL METRICS                 193

9.6           BRAND/SOFTWARE COMPARISON           194

9.7           COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024                 195

9.7.1        STARS   195

9.7.2        EMERGING LEADERS     195

9.7.3        PERVASIVE PLAYERS      195

9.7.4        PARTICIPANTS 195

9.7.5        COMPANY FOOTPRINT: KEY PLAYERS, 2024         197

9.7.5.1    Company footprint               197

9.7.5.2    Region footprint   198

9.7.5.3    Type of service footprint     199

9.7.5.4    End-user footprint                200

9.8           COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024        201

9.8.1        PROGRESSIVE COMPANIES         201

9.8.2        RESPONSIVE COMPANIES            201

9.8.3        DYNAMIC COMPANIES  201

9.8.4        STARTING BLOCKS         201

9.8.5        COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024                 203

9.8.5.1    Detailed list of key startups/SMEs    203

9.8.5.2    Competitive benchmarking of key startups/SMEs          203

9.9           COMPETITIVE SCENARIO             204

9.9.1        PRODUCT LAUNCHES   204

9.9.2        DEALS  204

9.9.3        EXPANSIONS     205

9.9.4        OTHER DEVELOPMENTS              206

10            COMPLNY PROFILE        207

10.1         KEY PLAYERS     207

10.1.1      ACCENTURE      207

10.1.1.1  Business overview 207

10.1.1.2  Products/Services/Solutions offered 208

10.1.1.3  Recent developments           209

10.1.1.3.1                Deals      209

10.1.1.4  MnM view              210

10.1.1.4.1                Key strengths        210

10.1.1.4.2                Strategic choices   210

10.1.1.4.3                Weaknesses and competitive threats 211

10.1.2      COGNIZANT      212

10.1.2.1  Business overview 212

10.1.2.2  Products/Services/Solutions offered 213

10.1.2.3  Recent developments           214

10.1.2.3.1                Deals      214

10.1.2.3.2                Expansions             215

10.1.2.4  MnM view              215

10.1.2.4.1                Key strengths        215

10.1.2.4.2                Strategic choices   215

10.1.2.4.3                Weaknesses and competitive threats 215

10.1.3      DELOITTE           216

10.1.3.1  Business overview 216

10.1.3.2  Products/Services/Solutions offered 216

10.1.3.3  Recent developments           217

10.1.3.3.1                Product launches  217

10.1.3.3.2                Deals      217

10.1.3.4  MnM view              218

10.1.3.4.1                Key strengths        218

10.1.3.4.2                Strategic choices   218

10.1.3.4.3                Weaknesses and competitive threats 218

10.1.4      MCKINSEY & COMPANY                 219

10.1.4.1  Business overview 219

10.1.4.2  Products/Services/Solutions offered 219

10.1.4.3  Recent developments           220

10.1.4.3.1                Product launches  220

10.1.4.4  Recent developments           221

10.1.4.4.1                Deals      221

10.1.4.5  MnM view              221

10.1.4.5.1                Key strengths        221

10.1.4.5.2                Strategic choices   221

10.1.4.5.3                Weaknesses and competitive threats 222

10.1.5      BOSTON CONSULTING GROUP 223

10.1.5.1  Business overview 223

10.1.5.2  Products/Services/Solutions offered 223

10.1.5.3  Recent developments           224

10.1.5.3.1                Deals      224

10.1.5.4  MnM view              224

10.1.5.4.1                Key strengths        224

10.1.5.4.2                Strategic choices   225

10.1.5.4.3                Weaknesses and competitive threats 225

10.1.6      PWC       226

10.1.6.1  Business overview 226

10.1.6.2  Products/Services/Solutions offered 226

10.1.6.3  Recent developments           227

10.1.6.3.1                Deals      227

10.1.7      EY           228

10.1.7.1  Business overview 228

10.1.7.2  Products/Services/Solutions offered 228

10.1.7.3  Recent developments           229

10.1.7.3.1                Product launches  229

10.1.8      HURON CONSULTING GROUP INC.         230

10.1.8.1  Business overview 230

10.1.8.2  Products/Services/Solutions offered 231

10.1.8.3  Recent developments           232

10.1.8.3.1                Deals      232

10.1.9      KPMG    233

10.1.9.1  Business overview 233

10.1.9.2  Products/Services/Solutions offered 234

10.1.9.3  Recent developments           236

10.1.9.3.1                Product launches  236

10.1.9.3.2                DEALS  237

10.1.10   BAIN & COMPANY, INC. 238

10.1.10.1                 Business overview 238

10.1.10.2                 Products/Services/Solutions offered 238

10.1.10.3                 Recent developments           239

10.1.10.3.1             Deals      239

10.1.11   IQVIA INC.           241

10.1.11.1                 Business overview 241

10.1.11.2                 Products/Services/Solutions offered 242

10.1.11.3                 Recent developments           244

10.1.11.3.1             Product launches  244

10.1.11.4                 Recent developments           244

10.1.11.4.1             Deals      244

10.1.12   L.E.K. CONSULTING        246

10.1.12.1                 Business overview 246

10.1.12.2                 Products/Services/Solutions offered 246

10.1.12.3                 Recent developments           247

10.1.12.3.1             Deals      247

10.1.12.3.2             Expansions             248

10.1.13   NTT DATA, INC.                249

10.1.13.1                 Business overview 249

10.1.13.2                 Products/Services/Solutions offered 250

10.1.13.3                 Recent developments           251

10.1.13.3.1             Product launches  251

10.1.13.3.2             Deals      251

10.1.14   OLIVER WYMAN, LLC     253

10.1.14.1                 Business overview 253

10.1.14.2                 Products/Services/Solutions offered 253

10.1.14.3                 Recent developments           254

10.1.14.3.1             Product launches  254

10.1.14.3.2             Deals      255

10.1.15   SIMON-KUCHER & PARTNERS    256

10.1.15.1                 Business overview 256

10.1.15.2                 Products/Services/Solutions offered 256

10.1.16   IBM        258

10.1.16.1                 Business overview 258

10.1.16.2                 Products/Services/Solutions offered 259

10.1.16.3                 Recent developments           261

10.1.16.3.1             Product launches  261

10.1.16.3.2             Deals      262

10.1.17   CLEARVIEW HEALTHCARE PARTNERS   263

10.1.17.1                 Business overview 263

10.1.17.2                 Products/Services/Solutions offered 263

10.1.17.3                 Recent developments           264

10.1.17.3.1             Other developments             264

10.1.18   ALVAREZ & MARSAL HOLDINGS, LLC     265

10.1.18.1                 Business overview 265

10.1.18.2                 Products offered   265

10.1.18.3                 Recent developments           266

10.1.18.3.1             Product launches  266

10.1.19   ZS ASSOCIATES 267

10.1.19.1                 Business overview 267

10.1.19.2                 Products/Services/Solutions offered 267

10.1.19.3                 Recent developments           268

10.1.19.3.1             Product launches  268

10.1.19.3.2             Deals      269

10.1.20   CHARTIS              270

10.1.20.1                 Business overview 270

10.1.20.2                 Products/Services/Solutions offered 270

10.1.20.3                 Recent developments           271

10.1.20.3.1             Deals      271

10.2         OTHER PLAYERS              272

10.2.1      QUALITY CREST HEALTHCARE CONSULTANTS PRIVATE LIMITED           272

10.2.2      LUCID HEALTH CONSULTING   273

10.2.3      BLUE MATTER CONSULTING     274

10.2.4      ISOS CONSULTANCY SERVICES PVT. LTD.            275

10.2.5      BACK BAY LIFE SCIENCE ADVISORS        276

11            APPENDIX           277

11.1         DISCUSSION GUIDE        277

11.2         KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL                281

11.3         CUSTOMIZATION OPTIONS        283

11.4         RELATED REPORTS         283

11.5         AUTHOR DETAILS           284

LIST OF TABLES

TABLE 1                HEALTHCARE CONSULTING SERVICES MARKET: INCLUSIONS AND EXCLUSIONS             27

TABLE 2                EXCHANGE RATES UTILIZED FOR CONVERSION TO USD, 2021–2024           28

TABLE 3                FACTOR ANALYSIS          40

TABLE 4                HEALTHCARE CONSULTING SERVICES MARKET: RISK ANALYSIS              45

TABLE 5                HEALTHCARE CONSULTING SERVICES MARKET: IMPACT ANALYSIS OF MARKET DYNAMICS     54

TABLE 6                INDICATIVE PRICING ANALYSIS FOR HEALTHCARE CONSULTING SERVICES,

BY TYPE, 2024     66

TABLE 7                HEALTHCARE CONSULTING SERVICES MARKET: ROLE OF COMPANIES IN ECOSYSTEM                69

TABLE 8                HEALTHCARE CONSULTING SERVICES MARKET: KEY CONFERENCES AND EVENTS, 2025–2026   73

TABLE 9                NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  76

TABLE 10              EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS           77

TABLE 11              ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS                 77

TABLE 12              LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  78

TABLE 13              MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  78

TABLE 14              HEALTHCARE CONSULTING SERVICES MARKET: PORTER’S FIVE FORCES ANALYSIS       81

TABLE 15              INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE END USERS  84

TABLE 16              KEY BUYING CRITERIA FOR TOP THREE END USERS   85

TABLE 17              US ADJUSTED RECIPROCAL TARIFF RATES                 87

TABLE 18             HEALTHCARE CONSULTING SERVICES MARKET, BY TYPE OF SERVICE,

2023–2030 (USD MILLION)            92

TABLE 19              KEY PLAYERS PROVIDING IT/DIGITAL TRANSFORMATION CONSULTING SERVICES      93

TABLE 20              IT/DIGITAL TRANSFORMATION CONSULTING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION)                 94

TABLE 21              KEY PLAYERS PROVIDING STRATEGY CONSULTING SERVICES                95

TABLE 22              STRATEGY CONSULTING SERVICES MARKET, BY REGION,

2023–2030 (USD MILLION)            95

TABLE 23              KEY PLAYERS PROVIDING OPERATIONS CONSULTING SERVICES                96

TABLE 24              OPERATIONS CONSULTING SERVICES MARKET, BY REGION,

2023–2030 (USD MILLION)            96

TABLE 25              KEY PLAYERS PROVIDING FINANCIAL CONSULTING SERVICES                97

TABLE 26              FINANCIAL CONSULTING SERVICES MARKET, BY REGION,

2023–2030 (USD MILLION)            98

TABLE 27              KEY PLAYERS PROVIDING HR & TALENT CONSULTING SERVICES                99

TABLE 28              HR & TALENT CONSULTING SERVICES MARKET, BY REGION,

2023–2030 (USD MILLION)            99

TABLE 29              KEY PLAYERS PROVIDING MARKETING, SALES, AND COMMERCIALIZATION CONSULTING SERVICES     100

TABLE 30              MARKETING, SALES & COMMERCIALIZATION CONSULTING SERVICES MARKET,

BY REGION, 2023–2030 (USD MILLION)   100

TABLE 31              KEY PLAYERS PROVIDING REGULATORY & COMPLIANCE CONSULTING SERVICES  101

TABLE 32              REGULATORY & COMPLIANCE CONSULTING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION)                 101

TABLE 33              KEY PLAYERS PROVIDING R&D CONSULTING SERVICES             102

TABLE 34              R&D CONSULTING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION)          102

TABLE 35              KEY PLAYERS PROVIDING PUBLIC HEALTH CONSULTING SERVICES                103

TABLE 36              PUBLIC HEALTH CONSULTING SERVICES MARKET, BY REGION,

2023–2030 (USD MILLION)            103

TABLE 37              KEY PLAYERS PROVIDING OTHER CONSULTING SERVICES             104

TABLE 38              OTHER CONSULTING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION)          104

TABLE 39             HEALTHCARE CONSULTING SERVICES MARKET, BY END USER,

2023–2030 (USD MILLION)            106

TABLE 40              HEALTHCARE CONSULTING SERVICES MARKET FOR GOVERNMENT BODIES,

BY REGION, 2023–2030 (USD MILLION)   107

TABLE 41              HEALTHCARE CONSULTING SERVICES MARKET FOR HEALTHCARE PROVIDERS,

BY TYPE, 2023–2030 (USD MILLION)         109

TABLE 42              HEALTHCARE CONSULTING SERVICES MARKET FOR HEALTHCARE PROVIDERS,

BY REGION, 2023–2030 (USD MILLION)   109

TABLE 43              HEALTHCARE CONSULTING SERVICES MARKET FOR HOSPITALS, BY REGION, 2023–2030 (USD MILLION)                 110

TABLE 44              HEALTHCARE CONSULTING SERVICES MARKET FOR AMBULATORY CARE CENTERS, BY REGION, 2023–2030 (USD MILLION)            112

TABLE 45              HEALTHCARE CONSULTING SERVICES MARKET FOR LONG-TERM CARE FACILITIES, BY REGION, 2023–2030 (USD MILLION)            113

TABLE 46              HEALTHCARE CONSULTING SERVICES MARKET FOR DIAGNOSTIC & IMAGING CENTERS, BY REGION, 2023–2030 (USD MILLION) 114

TABLE 47              HEALTHCARE CONSULTING SERVICES MARKET FOR OTHER HEALTHCARE PROVIDERS, BY REGION, 2023–2030 (USD MILLION) 114

TABLE 48              HEALTHCARE CONSULTING SERVICES MARKET FOR HEALTH INSURANCE PAYERS, BY TYPE, 2023–2030 (USD MILLION)            115

TABLE 49              HEALTHCARE CONSULTING SERVICES MARKET FOR HEALTH INSURANCE PAYERS, BY REGION, 2023–2030 (USD MILLION)            116

TABLE 50              HEALTHCARE CONSULTING SERVICES MARKET FOR PRIVATE PAYERS, BY REGION, 2023–2030 (USD MILLION)                 117

TABLE 51              HEALTHCARE CONSULTING SERVICES MARKET FOR PUBLIC PAYERS, BY REGION, 2023–2030 (USD MILLION)                 118

TABLE 52              HEALTHCARE CONSULTING SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2023–2030 (USD MILLION)          119

TABLE 53              HEALTHCARE CONSULTING SERVICES MARKET FOR MEDICAL DEVICE COMPANIES, BY REGION, 2023–2030 (USD MILLION)            120

TABLE 54              HEALTHCARE CONSULTING SERVICES MARKET FOR OTHER END USERS,

BY REGION, 2023–2030 (USD MILLION)   121

TABLE 55             HEALTHCARE CONSULTING SERVICES MARKET, BY REGION,

2023–2030 (USD MILLION)            123

TABLE 56              NORTH AMERICA: HEALTHCARE CONSULTING SERVICES MARKET,

BY COUNTRY, 2023–2030 (USD MILLION)               125

TABLE 57              NORTH AMERICA: HEALTHCARE CONSULTING SERVICES MARKET,

BY TYPE OF SERVICE, 2023–2030 (USD MILLION)                126

TABLE 58              NORTH AMERICA: HEALTHCARE CONSULTING SERVICES MARKET,

BY END USER, 2023–2030 (USD MILLION)               126

TABLE 59              NORTH AMERICA: HEALTHCARE CONSULTING SERVICES MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION)            127

TABLE 60              NORTH AMERICA: HEALTHCARE CONSULTING SERVICES MARKET FOR HEALTH INSURANCE PAYERS, BY TYPE 2023–2030 (USD MILLION)            127

TABLE 61              US: KEY MACROECONOMIC INDICATORS                 128

TABLE 62              US: HEALTHCARE CONSULTING SERVICES MARKET, BY TYPE OF SERVICE,

2023–2030 (USD MILLION)            129

TABLE 63              US: HEALTHCARE CONSULTING SERVICES MARKET, BY END USER,

2023–2030 (USD MILLION)            129

TABLE 64              US: HEALTHCARE CONSULTING SERVICES MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 130

TABLE 65              US: HEALTHCARE CONSULTING SERVICES MARKET FOR HEALTH INSURANCE PAYERS, BY TYPE 2023–2030 (USD MILLION) 130

TABLE 66              CANADA: KEY MACROECONOMIC INDICATORS                 131

TABLE 67              CANADA: HEALTHCARE CONSULTING SERVICES MARKET, BY TYPE OF SERVICE, 2023–2030 (USD MILLION)            131

TABLE 68              CANADA: HEALTHCARE CONSULTING SERVICES MARKET, BY END USER,

2023–2030 (USD MILLION)            132

TABLE 69              CANADA: HEALTHCARE CONSULTING SERVICES MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION)            132

TABLE 70              CANADA: HEALTHCARE CONSULTING SERVICES MARKET FOR HEALTH INSURANCE PAYERS, BY TYPE 2023–2030 (USD MILLION)            133

TABLE 71              EUROPE: HEALTHCARE CONSULTING SERVICES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            134

TABLE 72              EUROPE: HEALTHCARE CONSULTING SERVICES MARKET, BY TYPE OF SERVICE, 2023–2030 (USD MILLION)                 135

TABLE 73              EUROPE: HEALTHCARE CONSULTING SERVICES MARKET, BY END USER,

2023–2030 (USD MILLION)            135

TABLE 74              EUROPE: HEALTHCARE CONSULTING SERVICES MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 136

TABLE 75              EUROPE: HEALTHCARE CONSULTING SERVICES MARKET FOR HEALTH INSURANCE PAYERS, BY TYPE 2023–2030 (USD MILLION) 136

TABLE 76              GERMANY: KEY MACROECONOMIC INDICATORS      137

TABLE 77              GERMANY: HEALTHCARE CONSULTING SERVICES MARKET, BY TYPE OF SERVICE, 2023–2030 (USD MILLION)            137

TABLE 78              GERMANY: HEALTHCARE CONSULTING SERVICES MARKET, BY END USER,

2023–2030 (USD MILLION)            138

TABLE 79              GERMANY: HEALTHCARE CONSULTING SERVICES MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION)            138

TABLE 80              GERMANY: HEALTHCARE CONSULTING SERVICES MARKET FOR HEALTH INSURANCE PAYERS, BY TYPE 2023–2030 (USD MILLION)            139

TABLE 81              UK: KEY MACROECONOMIC INDICATORS                 140

TABLE 82              UK: HEALTHCARE CONSULTING SERVICES MARKET, BY TYPE OF SERVICE,

2023–2030 (USD MILLION)            141

TABLE 83              UK: HEALTHCARE CONSULTING SERVICES MARKET, BY END USER,

2023–2030 (USD MILLION)            141

TABLE 84              UK: HEALTHCARE CONSULTING SERVICES MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 142

TABLE 85              UK: HEALTHCARE CONSULTING SERVICES MARKET FOR HEALTH INSURANCE PAYERS, BY TYPE 2023–2030 (USD MILLION) 142

TABLE 86              FRANCE: KEY MACROECONOMIC INDICATORS                 143

TABLE 87              FRANCE: HEALTHCARE CONSULTING SERVICES MARKET, BY TYPE OF SERVICE, 2023–2030 (USD MILLION)                 143

TABLE 88              FRANCE: HEALTHCARE CONSULTING SERVICES MARKET, BY END USER,

2023–2030 (USD MILLION)            144

TABLE 89              FRANCE: HEALTHCARE CONSULTING SERVICES MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 144

TABLE 90              FRANCE: HEALTHCARE CONSULTING SERVICES MARKET FOR HEALTH INSURANCE PAYERS, BY TYPE 2023–2030 (USD MILLION) 145

TABLE 91              ITALY: KEY MACROECONOMIC INDICATORS                 146

TABLE 92              ITALY: HEALTHCARE CONSULTING SERVICES MARKET, BY TYPE OF SERVICE, 2023–2030 (USD MILLION)                 146

TABLE 93              ITALY: HEALTHCARE CONSULTING SERVICES MARKET, BY END USER,

2023–2030 (USD MILLION)            147

TABLE 94              ITALY: HEALTHCARE CONSULTING SERVICES MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 147

TABLE 95              ITALY: HEALTHCARE CONSULTING SERVICES MARKET FOR HEALTH INSURANCE PAYERS, BY TYPE 2023–2030 (USD MILLION) 148

TABLE 96              SPAIN: KEY MACROECONOMIC INDICATORS                 148

TABLE 97              SPAIN: HEALTHCARE CONSULTING SERVICES MARKET, BY TYPE OF SERVICE, 2023–2030 (USD MILLION)                 149

TABLE 98              SPAIN: HEALTHCARE CONSULTING SERVICES MARKET, BY END USER,

2023–2030 (USD MILLION)            149

TABLE 99              SPAIN: HEALTHCARE CONSULTING SERVICES MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 150

TABLE 100            SPAIN: HEALTHCARE CONSULTING SERVICES MARKET FOR HEALTH INSURANCE PAYERS, BY TYPE 2023–2030 (USD MILLION) 150

TABLE 101            REST OF EUROPE: HEALTHCARE CONSULTING SERVICES MARKET, BY TYPE

OF SERVICE, 2023–2030 (USD MILLION)  151

TABLE 102            REST OF EUROPE: HEALTHCARE CONSULTING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)                 151

TABLE 103            REST OF EUROPE: HEALTHCARE CONSULTING SERVICES MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION)            152

TABLE 104            REST OF EUROPE: HEALTHCARE CONSULTING SERVICES MARKET FOR HEALTH INSURANCE PAYERS, BY TYPE 2023–2030 (USD MILLION)            152

TABLE 105            ASIA PACIFIC: HEALTHCARE CONSULTING SERVICES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            155

TABLE 106            ASIA PACIFIC: HEALTHCARE CONSULTING SERVICES MARKET, BY TYPE OF SERVICE, 2023–2030 (USD MILLION)            155

TABLE 107            ASIA PACIFIC: HEALTHCARE CONSULTING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)                 156

TABLE 108            ASIA PACIFIC: HEALTHCARE CONSULTING SERVICES MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION)            156

TABLE 109            ASIA PACIFIC: HEALTHCARE CONSULTING SERVICES MARKET FOR HEALTH INSURANCE PAYERS, BY TYPE 2023–2030 (USD MILLION)            157

TABLE 110            JAPAN: KEY MACROECONOMIC INDICATORS                 158

TABLE 111            JAPAN: HEALTHCARE CONSULTING SERVICES MARKET, BY TYPE OF SERVICE, 2023–2030 (USD MILLION)                 158

TABLE 112            JAPAN: HEALTHCARE CONSULTING SERVICES MARKET, BY END USER,

2023–2030 (USD MILLION)            159

TABLE 113            JAPAN: HEALTHCARE CONSULTING SERVICES MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 159

TABLE 114            JAPAN: HEALTHCARE CONSULTING SERVICES MARKET FOR HEALTH INSURANCE PAYERS, BY TYPE 2023–2030 (USD MILLION) 160

TABLE 115            CHINA: KEY MACROECONOMIC INDICATORS                 161

TABLE 116            CHINA: HEALTHCARE CONSULTING SERVICES MARKET, BY TYPE OF SERVICE, 2023–2030 (USD MILLION)                 161

TABLE 117            CHINA: HEALTHCARE CONSULTING SERVICES MARKET, BY END USER,

2023–2030 (USD MILLION)            162

TABLE 118            CHINA: HEALTHCARE CONSULTING SERVICES MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 162

TABLE 119            CHINA: HEALTHCARE CONSULTING SERVICES MARKET FOR HEALTH INSURANCE PAYERS, BY TYPE 2023–2030 (USD MILLION) 163

TABLE 120            INDIA: KEY MACROECONOMIC INDICATORS                 164

TABLE 121            INDIA: HEALTHCARE CONSULTING SERVICES MARKET, BY TYPE OF SERVICE, 2023–2030 (USD MILLION)                 164

TABLE 122            INDIA: HEALTHCARE CONSULTING SERVICES MARKET, BY END USER,

2023–2030 (USD MILLION)            165

TABLE 123            INDIA: HEALTHCARE CONSULTING SERVICES MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 165

TABLE 124            INDIA: HEALTHCARE CONSULTING SERVICES MARKET FOR HEALTH INSURANCE PAYERS, BY TYPE 2023–2030 (USD MILLION) 166

TABLE 125            REST OF ASIA PACIFIC: HEALTHCARE CONSULTING SERVICES MARKET,

BY TYPE OF SERVICE, 2023–2030 (USD MILLION)                167

TABLE 126            REST OF ASIA PACIFIC: HEALTHCARE CONSULTING SERVICES MARKET,

BY END USER, 2023–2030 (USD MILLION)               167

TABLE 127            REST OF ASIA PACIFIC: HEALTHCARE CONSULTING SERVICES MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION)               168

TABLE 128            REST OF ASIA PACIFIC: HEALTHCARE CONSULTING SERVICES MARKET FOR HEALTH INSURANCE PAYERS, BY TYPE 2023–2030 (USD MILLION)        168

TABLE 129            LATIN AMERICA: HEALTHCARE CONSULTING SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)                 169

TABLE 130            LATIN AMERICA: HEALTHCARE CONSULTING SERVICES MARKET,

BY TYPE OF SERVICE, 2023–2030 (USD MILLION)                170

TABLE 131            LATIN AMERICA: HEALTHCARE CONSULTING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)                 170

TABLE 132            LATIN AMERICA: HEALTHCARE CONSULTING SERVICES MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION)            171

TABLE 133            LATIN AMERICA: HEALTHCARE CONSULTING SERVICES MARKET FOR HEALTH INSURANCE PAYERS, BY TYPE 2023–2030 (USD MILLION)            171

TABLE 134            BRAZIL: KEY MACROECONOMIC INDICATORS                 172

TABLE 135            BRAZIL: HEALTHCARE CONSULTING SERVICES MARKET, BY TYPE OF SERVICE, 2023–2030 (USD MILLION)                 172

TABLE 136            BRAZIL: HEALTHCARE CONSULTING SERVICES MARKET, BY END USER,

2023–2030 (USD MILLION)            173

TABLE 137            BRAZIL: HEALTHCARE CONSULTING SERVICES MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 173

TABLE 138            BRAZIL: HEALTHCARE CONSULTING SERVICES MARKET FOR HEALTH INSURANCE PAYERS, BY TYPE 2023–2030 (USD MILLION) 174

TABLE 139            MEXICO: KEY MACROECONOMIC INDICATORS                 174

TABLE 140            MEXICO: HEALTHCARE CONSULTING SERVICES MARKET, BY TYPE OF SERVICE, 2023–2030 (USD MILLION)                 175

TABLE 141            MEXICO: HEALTHCARE CONSULTING SERVICES MARKET, BY END USER,

2023–2030 (USD MILLION)            175

TABLE 142            MEXICO: HEALTHCARE CONSULTING SERVICES MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 176

TABLE 143            MEXICO: HEALTHCARE CONSULTING SERVICES MARKET FOR HEALTH INSURANCE PAYERS, BY TYPE 2023–2030 (USD MILLION) 176

TABLE 144            REST OF LATIN AMERICA: HEALTHCARE CONSULTING SERVICES MARKET,

BY TYPE OF SERVICE, 2023–2030 (USD MILLION)                177

TABLE 145            REST OF LATIN AMERICA: HEALTHCARE CONSULTING SERVICES MARKET,

BY END USER, 2023–2030 (USD MILLION)               177

TABLE 146            REST OF LATIN AMERICA: HEALTHCARE CONSULTING SERVICES MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION)               178

TABLE 147            REST OF LATIN AMERICA: HEALTHCARE CONSULTING SERVICES MARKET FOR HEALTH INSURANCE PAYERS, BY TYPE 2023–2030 (USD MILLION)        178

TABLE 148            MIDDLE EAST & AFRICA: HEALTHCARE CONSULTING SERVICES MARKET,

BY REGION, 2023–2030 (USD MILLION)   179

TABLE 149            MIDDLE EAST & AFRICA: HEALTHCARE CONSULTING SERVICES MARKET,

BY TYPE OF SERVICE, 2023–2030 (USD MILLION)                180

TABLE 150            MIDDLE EAST & AFRICA: HEALTHCARE CONSULTING SERVICES MARKET,

BY END USER, 2023–2030 (USD MILLION)               180

TABLE 151            MIDDLE EAST & AFRICA: HEALTHCARE CONSULTING SERVICES MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION)               181

TABLE 152            MIDDLE EAST & AFRICA: HEALTHCARE CONSULTING SERVICES MARKET FOR HEALTH INSURANCE PAYERS, BY TYPE 2023–2030 (USD MILLION)        181

TABLE 153            GCC COUNTRIES: HEALTHCARE CONSULTING SERVICES MARKET, BY TYPE OF SERVICE, 2023–2030 (USD MILLION)            182

TABLE 154            GCC COUNTRIES: HEALTHCARE CONSULTING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)                 183

TABLE 155            GCC COUNTRIES: HEALTHCARE CONSULTING SERVICES MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION)            183

TABLE 156            GCC COUNTRIES: HEALTHCARE CONSULTING SERVICES MARKET FOR HEALTH INSURANCE PAYERS, BY TYPE 2023–2030 (USD MILLION)            184

TABLE 157            REST OF MIDDLE EAST & AFRICA: HEALTHCARE CONSULTING SERVICES MARKET, BY TYPE OF SERVICE, 2023–2030 (USD MILLION)       185

TABLE 158            REST OF MIDDLE EAST & AFRICA: HEALTHCARE CONSULTING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)            185

TABLE 159            REST OF MIDDLE EAST & AFRICA: HEALTHCARE CONSULTING SERVICES MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION)               186

TABLE 160            REST OF MIDDLE EAST & AFRICA: HEALTHCARE CONSULTING SERVICES MARKET FOR HEALTH INSURANCE PAYERS, BY TYPE 2023–2030 (USD MILLION)        186

TABLE 161            OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN HEALTHCARE CONSULTING SERVICES MARKET, JANUARY 2022–MAY 2025               187

TABLE 162            HEALTHCARE CONSULTING SERVICES MARKET: DEGREE OF COMPETITION    191

TABLE 163            HEALTHCARE CONSULTING SERVICES MARKET: REGION FOOTPRINT, 2024       198

TABLE 164            HEALTHCARE CONSULTING SERVICES MARKET: TYPE OF SERVICE

FOOTPRINT, 2024             199

TABLE 165            HEALTHCARE CONSULTING SERVICES MARKET: END-USER FOOTPRINT, 2024  200

TABLE 166            HEALTHCARE CONSULTING SERVICES MARKET: DETAILED LIST OF KEY STARTUPS/SMES         203

TABLE 167            HEALTHCARE CONSULTING SERVICES MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES              203

TABLE 168            HEALTHCARE CONSULTING SERVICES MARKET: PRODUCT LAUNCHES, JANUARY 2022–MAY 2025                 204

TABLE 169            HEALTHCARE CONSULTING SERVICES MARKET: DEALS, JANUARY 2022–MAY 2025            204

TABLE 170            HEALTHCARE CONSULTING SERVICES MARKET: EXPANSIONS,

JANUARY 2022–MAY 2025               205

TABLE 171            HEALTHCARE CONSULTING SERVICES MARKET: OTHER DEVELOPMENTS,

JANUARY 2022–MAY 2025               206

TABLE 172            ACCENTURE: COMPANY OVERVIEW       207

TABLE 173            ACCENTURE: PRODUCTS/SERVICES/SOLUTIONS OFFERED    208

TABLE 174            ACCENTURE: DEALS, JANUARY 2022–MAY 2025                 209

TABLE 175            COGNIZANT: COMPANY OVERVIEW       212

TABLE 176            COGNIZANT: PRODUCTS/SERVICES/SOLUTIONS OFFERED    213

TABLE 177            COGNIZANT: DEALS, JANUARY 2022–MAY 2025                 214

TABLE 178            COGNIZANT: EXPANSIONS, JANUARY 2022–MAY 2025        215

TABLE 179            DELOITTE: COMPANY OVERVIEW           216

TABLE 180            DELOITTE: PRODUCTS/SERVICES/SOLUTIONS OFFERED             216

TABLE 181            DELOITTE: PRODUCT LAUNCHES, JANUARY 2022–MAY 2025   217

TABLE 182            DELOITTE: DEALS, JANUARY 2022–MAY 2025                 217

TABLE 183            MCKINSEY & COMPANY: COMPANY OVERVIEW                 219

TABLE 184            MCKINSEY & COMPANY: PRODUCTS/SERVICES/SOLUTIONS OFFERED    219

TABLE 185            MCKINSEY & COMPANY: PRODUCT LAUNCHES, JANUARY 2022–MAY 2025               220

TABLE 186            MCKINSEY & COMPANY: DEALS, JANUARY 2022–MAY 2025              221

TABLE 187            BOSTON CONSULTING GROUP: COMPANY OVERVIEW          223

TABLE 188            BOSTON CONSULTING GROUP: PRODUCTS/SERVICES/SOLUTIONS OFFERED    223

TABLE 189            BOSTON CONSULTING GROUP: DEALS, JANUARY 2022– MAY 2025              224

TABLE 190            PWC: COMPANY OVERVIEW       226

TABLE 191            PWC: PRODUCTS/SERVICES/SOLUTIONS OFFERED             226

TABLE 192            PWC: DEALS, JANUARY 2022–MAY 2025   227

TABLE 193            EY: COMPANY OVERVIEW            228

TABLE 194            EY: PRODUCTS/SERVICES/SOLUTIONS OFFERED             228

TABLE 195            EY: PRODUCT LAUNCHES, JANUARY 2022– MAY 2025        229

TABLE 196            HURON CONSULTING GROUP INC.: COMPANY OVERVIEW          230

TABLE 197            HURON CONSULTING GROUP INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED    231

TABLE 198            HURON CONSULTING GROUP INC.: DEALS, JANUARY 2022– MAY 2025              232

TABLE 199            KPMG: COMPANY OVERVIEW    233

TABLE 200            KPMG: PRODUCTS/SERVICES/SOLUTIONS OFFERED             234

TABLE 201            KPMG: PRODUCT LAUNCHES, JANUARY 2022– MAY 2025              236

TABLE 202            KPMG: DEALS, JANUARY 2022– MAY 2025                 237

TABLE 203            BAIN & COMPANY, INC.: COMPANY OVERVIEW                 238

TABLE 204            BAIN & COMPANY, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED    238

TABLE 205            BAIN & COMPANY, INC.: DEALS, JANUARY 2022– MAY 2025              239

TABLE 206            IQVIA INC.: COMPANY OVERVIEW            241

TABLE 207            IQVIA, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED             242

TABLE 208            IQVIA, INC.: PRODUCT LAUNCHES, JANUARY 2022– MAY 2025  244

TABLE 209            IQVIA, INC.: DEALS, JANUARY 2022– MAY 2025                 244

TABLE 210            L.E.K CONSULTING: COMPANY OVERVIEW                 246

TABLE 211            L.E.K CONSULTING: PRODUCTS/SERVICES/SOLUTIONS OFFERED    246

TABLE 212            L.E.K. CONSULTING: DEALS, JANUARY 2022–MAY 2025              247

TABLE 213            L.E.K CONSULTING: EXPANSIONS, JANUARY 2022–MAY 2025   248

TABLE 214            NTT DATA, INC.: COMPANY OVERVIEW 249

TABLE 215            NTT DATA, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED    250

TABLE 216            NTT DATA, INC.: PRODUCT LAUNCHES, JANUARY 2022–MAY 2025               251

TABLE 217            NTT DATA, INC.: DEALS, JANUARY 2022–MAY 2025        251

TABLE 218            OLIVER WYMAN, LLC: COMPANY OVERVIEW                 253

TABLE 219            OLIVER WYMAN, LLC: PRODUCTS/SERVICES/SOLUTIONS OFFERED    253

TABLE 220            OLIVER WYMAN, LLC: PRODUCT LAUNCHES, JANUARY 2022–MAY 2025               254

TABLE 221            OLIVER WYMAN, LLC: DEALS, JANUARY 2022–MAY 2025              255

TABLE 222            SIMON-KUCHER & PARTNERS: COMPANY OVERVIEW          256

TABLE 223            SIMON-KUCHER & PARTNERS: PRODUCTS/SERVICES/SOLUTIONS OFFERED    256

TABLE 224            IBM: COMPANY OVERVIEW         258

TABLE 225            IBM: PRODUCTS/SERVICES/SOLUTIONS OFFERED             259

TABLE 226            IBM: PRODUCT LAUNCHES, JANUARY 2022–MAY 2025        261

TABLE 227            IBM: DEALS, JANUARY 2022–MAY 2025     262

TABLE 228            CLEARVIEW HEALTHCARE PARTNERS: COMPANY OVERVIEW   263

TABLE 229            CLEARVIEW HEALTHCARE PARTNERS: PRODUCTS/SERVICES/SOLUTIONS OFFERED    263

TABLE 230            CLEARVIEW HEALTHCARE PARTNER: OTHER DEALS, JANUARY 2022–MAY 2025                264

TABLE 231            ALVAREZ & MARSAL HOLDINGS, LLC: COMPANY OVERVIEW   265

TABLE 232            ALVAREZ & MARSAL HOLDINGS, LLC: PRODUCTS OFFERED    265

TABLE 233            ALVAREZ & MARSAL HOLDINGS, LLC: PRODUCT LAUNCHES,

JANUARY 2022–MAY 2024               266

TABLE 234            ZS ASSOCIATES: COMPANY OVERVIEW 267

TABLE 235            ZS ASSOCIATES: PRODUCTS/SERVICES/SOLUTIONS OFFERED    267

TABLE 236            ZS ASSOCIATES: PRODUCT LAUNCHES, JANUARY 2022–MAY 2025               268

TABLE 237            ZS ASSOCIATES: DEALS, JANUARY 2022–MAY 2025        269

TABLE 238            CHARTIS: COMPANY OVERVIEW               270

TABLE 239            CHARTIS: PRODUCTS/SERVICES/SOLUTIONS OFFERED             270

TABLE 240            CHARTIS: DEALS, JANUARY 2022–MAY 2025                 271

TABLE 241            QUALITY CREST HEALTHCARE CONSULTANTS PRIVATE LIMITED:

COMPANY OVERVIEW   272

TABLE 242            LUCID HEALTH CONSULTING: COMPANY OVERVIEW          273

TABLE 243            BLUE MATTER CONSULTING: COMPANY OVERVIEW          274

TABLE 244            ISOS CONSULTANCY SERVICES PVT. LTD.: COMPANY OVERVIEW   275

TABLE 245            BACK BAY LIFE SCIENCE ADVISORS: COMPANY OVERVIEW          276

LIST OF FIGURES

FIGURE 1              HEALTHCARE CONSULTING SERVICES MARKET SEGMENTATION AND REGIONAL SCOPE              26

FIGURE 2              RESEARCH DESIGN         30

FIGURE 3              PRIMARY SOURCES         32

FIGURE 4              INSIGHTS FROM INDUSTRY EXPERTS     34

FIGURE 5              BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION,

AND REGION     34

FIGURE 6              RESEARCH METHODOLOGY: HYPOTHESIS BUILDING           35

FIGURE 7              SUPPLY-SIDE MARKET ESTIMATION      37

FIGURE 8              HEALTHCARE CONSULTING SERVICES MARKET: REVENUE ESTIMATION APPROACH    37

FIGURE 9              BOTTOM-UP APPROACH: COLLECTIVE REVENUE OF ALL SERVICES/SOLUTIONS OF VENDORS 39

FIGURE 10            CAGR PROJECTIONS FROM ANALYSIS OF MARKET DYNAMICS, 2024–2030  41

FIGURE 11            CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS                 41

FIGURE 12            TOP-DOWN APPROACH                42

FIGURE 13            DATA TRIANGULATION METHODOLOGY                 43

FIGURE 14           HEALTHCARE CONSULTING SERVICES MARKET, BY TYPE OF SERVICE,

2025 VS. 2030 (USD MILLION)      46

FIGURE 15           HEALTHCARE CONSULTING SERVICES MARKET, BY END USER,

2025 VS. 2030 (USD MILLION)      47

FIGURE 16            GEOGRAPHIC SNAPSHOT OF HEALTHCARE CONSULTING SERVICES MARKET             48

FIGURE 17            GROWING ADOPTION OF HEALTHCARE IT SOLUTIONS TO DRIVE MARKET                49

FIGURE 18            PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES SEGMENT AND JAPAN LED ASIA PACIFIC MARKET IN 2024  50

FIGURE 19            INDIA TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD       51

FIGURE 20            NORTH AMERICA TO DOMINATE MARKET DURING FORECAST PERIOD       51

FIGURE 21            EMERGING MARKETS TO REGISTER HIGHER GROWTH DURING FORECAST PERIOD  52

FIGURE 22            HEALTHCARE CONSULTING SERVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES    53

FIGURE 23            MEDIAN HEALTHCARE DATA BREACH IN US, 2009–2024              59

FIGURE 24            NEW REVENUE POCKETS FOR PLAYERS IN HEALTHCARE CONSULTING SERVICES MARKET               65

FIGURE 25            HEALTHCARE CONSULTING SERVICES MARKET: VALUE CHAIN ANALYSIS           67

FIGURE 26            HEALTHCARE CONSULTING SERVICES MARKET: ECOSYSTEM ANALYSIS              68

FIGURE 27            INVESTMENT AND FUNDING SCENARIO, 2019–2024        70

FIGURE 28            HEALTHCARE CONSULTING SERVICES MARKET: PORTER’S FIVE FORCES ANALYSIS       82

FIGURE 29            INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE

END USERS         84

FIGURE 30            KEY BUYING CRITERIA FOR TOP THREE END USERS   85

FIGURE 31            NORTH AMERICA: HEALTHCARE CONSULTING SERVICES MARKET SNAPSHOT  124

FIGURE 32            ASIA PACIFIC: HEALTHCARE CONSULTING SERVICES MARKET SNAPSHOT  154

FIGURE 33            REVENUE ANALYSIS OF KEY PLAYERS IN HEALTHCARE CONSULTING SERVICES MARKET, 2020–2024 (USD MILLION)            190

FIGURE 34            HEALTHCARE CONSULTING SERVICES MARKET SHARE ANALYSIS OF

KEY PLAYERS, 2024           191

FIGURE 35            EV/EBITDA OF KEY VENDORS, 2024         193

FIGURE 36            YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND A 5-YEAR STOCK BETA OF HEALTHCARE CONSULTING SERVICES VENDORS, 2024             193

FIGURE 37            HEALTHCARE CONSULTING SERVICES MARKET: BRAND/SOFTWARE COMPARISON       194

FIGURE 38            HEALTHCARE CONSULTING SERVICES MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024                 196

FIGURE 39            HEALTHCARE CONSULTING SERVICES MARKET: COMPANY FOOTPRINT

(KEY PLAYERS), 2024       197

FIGURE 40            HEALTHCARE CONSULTING SERVICES MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024        202

FIGURE 41            ACCENTURE: COMPANY SNAPSHOT (2024)                 208

FIGURE 42            COGNIZANT: COMPANY SNAPSHOT (2024)                 213

FIGURE 43            HURON CONSULTING GROUP INC.: COMPANY SNAPSHOT (2024)             230

FIGURE 44            KPMG: COMPANY SNAPSHOT (2024)       234

FIGURE 45            IQVIA, INC.: COMPANY SNAPSHOT (2024)                 242

FIGURE 46            NTT DATA, INC.: COMPANY SNAPSHOT (2024)                 249

FIGURE 47            IBM: COMPANY SNAPSHOT (2024)            259

MarketsandMarkets（マーケッツアンドマーケッツ）は世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。広範な市場を対象にした市場調査レポートを出版しています。

※MarketsandMarketsの調査レポートはほぼ全タイトルご注文後、最短3時間～12時間以内（営業日基準）にご納品可能です。

ライセンス別価格表

調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。

ライセンスタイプ1

ライセンスタイプ2

ライセンスタイプ3

ライセンスタイプ4

ミニレポート　※定性調査にフォーカスした調査レポートです。詳細はお問合せください。

ご購入に関するご案内

価格・納期について

• 価格
  • ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
• ライセンス
  • シングルユーザライセンス
    • 1名のみレポートファイルのご利用が可能です。
  • マルチユーザライセンス
    • 同一企業内（関連会社除く）5名までレポートファイルのご利用が可能です。
  • コーポレートライセンス
    • 同一企業および100％持株会社間・人数無制限でレポートファイルのご利用が可能です。
  • エンタープライズサイトライセンス
    • 特別ライセンスです。適用範囲についてはお問合せください。
• 納品形態
  • Eメール
• 納期
  • 最短3時間以内にご納品可能です。通常ご注文後24時間以内（営業日基準）

ご注文方法

• レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。

その他

• 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。

株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。

最新調査レポート

• 自動車用アラミド繊維市場規模、シェア、動向、2030年までの世界予測 2025-12-15
• ポリヒドロキシアルカノエート (PHA) 市場規模、シェア、動向、2030年までの世界予測 2025-12-15
• 複合輸送市場規模、シェア、動向、2032年までの世界予測 2025-12-12
• 有機酸市場規模、シェア、動向、2030年までの世界予測 2025-12-11
• ハイブリッドボンディング市場規模、シェア、動向、2032年までの世界予測 2025-12-11

MarketsandMarkets  出版レポート一覧